OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
The gut microbiome is a critical mediator in the interaction between an individual and their nutritional environment. As such, it has great potential as a target for the prevention and treatment of diet-related metabolic diseases.
This talk reports recent large-scale, multi-omic studies of the gut microbiome in type 2 diabetes and non-alcoholic fatty liver disease. In doing so, it addresses the role of microbially-mediated inflammation in the onset and development of both diseases. It also highlights the challenges inherent in microbiome studies, where causality may be attributed at the level of a single species, a clade, or a complex community.
